75 results
Page 4 of 4
6-K
EX-99.1
grqo a5kdrt
22 Oct 18
Phase 3 Data on Filgotinib In Biologic-experienced Rheumatoid Arthritis to Be Presented at 2018 Acr/arhp Annual Meeting
6:05am
6-K
EX-99.2
i1at26d5n4ir
2 Aug 18
Current report (foreign)
4:03pm
6-K
EX-99.1
j1ziqtm
9 Jul 18
Galapagos announces design for PINTA Phase 2 trial with GLPG1205 in IPF
6:10am
6-K
EX-99.1
efkmrnjt6phpahyn
22 May 18
GLPG1690 results in IPF published in The Lancet Respiratory Medicine and presented at ATS
6:00am
6-K
EX-99.1
shplni0c93malyrd
2 May 18
Galapagos and MorphoSys announce initiation of the IGUANA Phase 2 clinical trial with MOR106 in atopic dermatitis patients
6:00am
6-K
EX-99.2
6avg7ddj6wfkqugo
27 Apr 18
Galapagos reports first quarter 2018 results
12:00am
6-K
EX-99
2rbv 06ojvhhajb35f
4 Apr 17
Galapagos announces three new Phase 2 Proof-of-Concept studies with filgotinib
12:00am
6-K
EX-99.1
gt6rw uq4
22 Apr 16
Galapagos reports additional data with filgotinib from the Phase 2 FITZROY study
12:00am
20-F
4wkjfq57gg8
25 Mar 16
Annual report (foreign)
12:00am
6-K
EX-99
60gfgbwo
20 Oct 15
Form 6-K Filing Document
12:00am
6-K
EX-99
558ca
20 Oct 15
Form 6-K Filing Document
12:00am
DRS/A
EX-10
c28o6n
4 Mar 15
Draft registration statement (amended)
12:00am
DRS
n72iy653k0 6q1b9l0
6 Feb 15
Draft registration statement
12:00am